EFG Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

EFG Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.38M	Sell	4,035 -1,327	-25%	-$403K	0.18%	155
2025 Q2	$1.3M	Sell	5,362 -2,258	-30%	-$554K	0.18%	157
2025 Q1	$2.07M	Sell	7,620 -2,366	-24%	-$553K	0.34%	126
2024 Q4	$1.85M	Sell	9,986 -3,489	-26%	-$713K	0.25%	160
2024 Q3	$3.03M	Sell	13,475 -4,305	-24%	-$775K	0.51%	70
2024 Q2	$2.54M	Buy	17,780 +3,170	+22%	+$489K	0.44%	82
2024 Q1	$2.28M	Buy	14,610 +4,684	+47%	+$754K	0.39%	100
2023 Q4	$1.79M	Sell	9,926 -443	-4%	-$80.1K	0.34%	116
2023 Q3	$1.86M	Buy	10,369 +925	+10%	+$183K	0.44%	75
2023 Q2	$1.68M	Buy	+9,444	New	+$2.17M	0.36%	94

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EFG Asset Management's ONC Position: Q3 2025 in Review

EFG Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 25% in Q3 2025, selling an estimated $403K and leaving 4,035 shares worth $1.38M. The position accounts for 0.18% of the portfolio, ranked #155.

EFG Asset Management first reported a position in ONC in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.03M in Q3 2024. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

EFG Asset Management held 4,035 shares of BeOne Medicines Ltd worth $1.38M as of Q3 2025.
EFG Asset Management sold 1,327 BeOne Medicines Ltd shares in Q3 2025, an estimated $403K.
BeOne Medicines Ltd made up 0.18% of EFG Asset Management's portfolio in Q3 2025, its #155 holding.
EFG Asset Management first reported a position in BeOne Medicines Ltd in Q2 2023 and has held it in 10 quarters since.
EFG Asset Management's BeOne Medicines Ltd position peaked at $3.03M in Q3 2024.
266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.